Skip to main content
. 2018 Sep 24;17:1533033818801809. doi: 10.1177/1533033818801809

Figure 2.

Figure 2.

Gene subtype detection in circulating tumor DNA (ctDNA). Cell-free DNA (cfDNA) is isolated from blood collected from patients with lung cancer. Circulating tumor DNA accounts for a small ratio of cfDNA fragments. Droplet digital PCR (ddPCR) and next-generation sequencing (NGS) are performed to test alterations in the lung cancer driver gene including gene mutation, copy number variations, and fusion genes.